研究紹介(論文)

小髙 雅人(Masahito Kotaka)

役職:research_staff_7_position

2019年

英文論文
SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer
国内講演
大腸癌チーム医療セミナー in IWATE
市民公開講座 知ろう大腸がん!知れば安心!大腸がん治療最前線
Chugai Colorectal Cancer Symposiu in KOBE
Cancer VTEセミナー

2018年

英文論文
Tumor sidedness and enriched gene groups for efficacy of first-line cetuximab treatment in metastatic colorectal cancer
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane
A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial
Safety data from the phase III Japanese ACHIEVE trial: part of an international,prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as、 second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial
Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402)
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
国内講演
消化器がんセミナーin熊谷2018
大腸癌治療セミナー in Kobe
大腸がんセミナーin塩釜
第56回日本癌治療学会学術集会
桑名地区消化器癌治療講演会
垂水区消化器癌化学療法セミナー
消化器がんチーム医療セミナー
Colorectal Cancer Symposium in Shidahaibara
大腸がんチーム医療講演会in Kawasaki ~がん化学療法におけるチーム医療の実際~
Meet The Expert
西区がん化学療法講演会
大腸がんチーム医療セミナー
垂水消化器癌連携セミナー
Colorectal Cancer Winter Forum

2017年

英文論文
CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer
国内講演
消化器がんチーム医療セミナー ~がん化学療法におけるチーム医療の実際~
大腸癌チーム医療セミナーin 都城